Sanders Adam sold $395K of AMAT

Applied Materials (AMAT) shares fell 1.7% to $456.36 on October 14, despite outlining 2030 targets including 54% gross margin, 40% operating margin, and $12B in services revenue. The company plans to return 80-100% of free cash flow to shareholders, but lacks near-term demand forecasts.

Applied Materials opened the EPIC Center, the world's largest semiconductor R&D facility, in California. The $5 billion investment spans 55,700 sq. meters and includes partners like TSMC, Intel, and Samsung. The center aims to accelerate semiconductor innovation by integrating research, development, and production.

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

Applied Materials (AMAT) expects to gain market share in wafer-fab equipment, leading-edge logic, DRAM, and advanced packaging by 2030. The company anticipates revenue growth in process control and services, with AIx platform improving yield and factory output. Financial targets include $12B+ in services revenue and 54% gross margin by 2030. AMAT plans to return 80-100% of free cash flow to shareholders.

Applied Materials (AMAT) shares fell 7.2% after an investor presentation lacked revenue growth projections. The company forecast 2030 margins of 54% gross and 40% operating, with services revenue exceeding $12B. Investors reacted negatively to the absence of overall revenue guidance, despite bullish long-term outlooks on AI-driven growth.

JPMorgan Chase (JPM) missed Q3 earnings estimates, with Fixed Income & Markets revenue falling 4% Y/Y. Goldman Sachs (GS) beat estimates, while Wells Fargo (WFC) and Citigroup (C) showed mixed results. UnitedHealth Group (UNH) raised its full-year outlook, and Johnson & Johnson (JNJ) reported a Q3 beat but saw shares weighed down by MedTech revenue. Applied Materials (AMAT) declined post-investor presentation. Fund managers increased tech sector exposure to a six-year high.